Arko Corp.
Arko Corp. (ARKOW) Financial Performance & Income Statement Overview
Analyze Arko Corp. (ARKOW) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Arko Corp. (ARKOW) Income Statement & Financial Overview
Review Arko Corp. ARKOW income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $1.83B | $1.99B | $2.28B | $2.39B |
| Cost of Revenue | $1.56B | $1.90B | $2.16B | $2.30B |
| Gross Profit | $266.93M | $58.03M | $114.50M | $85.64M |
| Gross Profit Ratio | $0.15 | $0.03 | $0.05 | $0.04 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $41.61M | $39.69M | $38.64M | $40.93M |
| Operating Expenses | $276.48M | $77.64M | $72.93M | $40.93M |
| Total Costs & Expenses | $1.84B | $1.98B | $2.24B | $2.34B |
| Interest Income | $9.47M | $4.13M | $3.13M | $3.38M |
| Interest Expense | $23.33M | $23.84M | $26.76M | $24.75M |
| Depreciation & Amortization | $34.89M | $33.99M | $33.13M | $33.58M |
| EBITDA | $32.60M | $52.39M | $77.84M | $79.81M |
| EBITDA Ratio | $0.02 | $0.03 | $0.03 | $0.03 |
| Operating Income | -$9.55M | $14.38M | $41.57M | $44.72M |
| Operating Income Ratio | -$0.005 | $0.007 | $0.02 | $0.02 |
| Other Income/Expenses (Net) | -$16.07M | -$19.71M | -$23.62M | -$23.14M |
| Income Before Tax | -$25.61M | -$5.34M | $17.95M | $21.58M |
| Income Before Tax Ratio | -$0.01 | -$0.003 | $0.008 | $0.009 |
| Income Tax Expense | -$12.92M | -$3.00M | $8.30M | $7.55M |
| Net Income | -$12.69M | -$2.30M | $26.25M | $14.06M |
| Net Income Ratio | -$0.007 | -$0.001 | $0.01 | $0.006 |
| EPS | -$0.12 | -$0.03 | $0.07 | $0.11 |
| Diluted EPS | -$0.12 | -$0.03 | $0.07 | $0.11 |
| Weighted Avg Shares Outstanding | $115.88M | $115.77M | $115.77M | $115.76M |
| Weighted Avg Shares Outstanding (Diluted) | $115.88M | $115.77M | $117.89M | $116.88M |
Over the past four quarters, Arko Corp. demonstrated steady revenue growth, increasing from $2.39B in Q2 2024 to $1.83B in Q1 2025. Operating income reached -$9.55M in Q1 2025, maintaining a consistent -1% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $32.60M, reflecting operational efficiency. Net income dropped to -$12.69M, with EPS at -$0.12. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan